Table 2

 White matter lesion quantification in patients with Fabry disease and in controls

WML classificationMale Fabry patientsFemale Fabry patientsMale controlsFemale controls
nAgenAgenAgenAge
WML, White matter lesion.
Mild WMLs, single, non-confluent bright lesions; significant WMLs, multiple (> 5) or confluent lesions.
No WML426.8 (7.0)730.7 (11.0)934.1 (8.3)734.1 (8.4)
Mild WMLs230.0 (4.0)539.4 (9.6)335.3 (17.1)149.0
Significant WMLs448.5 (5.7)346.0 (10.1)00